{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:53:34Z","timestamp":1777949614643,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272753"],"award-info":[{"award-number":["82272753"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Collaborative Academic Innovation Project of Shandong Cancer Hospital","award":["ZF004"],"award-info":[{"award-number":["ZF004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02158-8","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:50:34Z","timestamp":1777863034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic changes in gut microbiota and discovery of prognostic biomarkers in locally advanced pancreatic cancer during chemoradiotherapy"],"prefix":"10.1007","volume":"26","author":[{"given":"Haohua","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benkui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"2158_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma[J]. N Engl J Med. 2014;371:1039\u201349.","journal-title":"N Engl J Med"},{"key":"2158_CR2","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, et al. Pancreatic cancer[J]. Nat Rev Dis Primers. 2016;2:16022.","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 5","key":"2158_CR3","doi-asserted-by":"publisher","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","volume":"26","author":"M Ducreux","year":"2015","unstructured":"Ducreux M, Cuhna AS, Caramella C, et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol. 2015;26(Suppl 5):v56\u201368.","journal-title":"Ann Oncol"},{"key":"2158_CR4","first-page":"11","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2158_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/annonc\/mdx174","volume":"28","author":"J Taieb","year":"2017","unstructured":"Taieb J, Pointet AL, Van Laethem JL, et al. What treatment in 2017 for inoperable pancreatic cancers?[J]. Ann Oncol. 2017;28:1473\u201383.","journal-title":"Ann Oncol"},{"key":"2158_CR6","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1001\/jama.2016.4324","volume":"315","author":"P Hammel","year":"2016","unstructured":"Hammel P, Huguet F, van Laethem JL, et al. Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial[J]. JAMA. 2016;315:1844\u201353.","journal-title":"JAMA"},{"key":"2158_CR7","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine[J]. N Engl J Med. 2013;369:1691\u2013703.","journal-title":"N Engl J Med"},{"key":"2158_CR8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jama.2010.1275","volume":"304","author":"JP Neoptolemos","year":"2010","unstructured":"Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial[J]. JAMA. 2010;304:1073\u201381.","journal-title":"JAMA"},{"key":"2158_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer[J]. N Engl J Med. 2011;364:1817\u201325.","journal-title":"N Engl J Med"},{"key":"2158_CR10","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jamaoncol.2022.0494","volume":"8","author":"L Liu","year":"2022","unstructured":"Liu L, Shah K. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review[J]. JAMA Oncol. 2022;8:1059\u201367.","journal-title":"JAMA Oncol"},{"key":"2158_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","volume":"8","author":"LY Zhao","year":"2023","unstructured":"Zhao LY, Mei JX, Yu G, et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications[J]. Signal Transduct Target Ther. 2023;8:201.","journal-title":"Signal Transduct Target Ther"},{"key":"2158_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","volume":"164","author":"D Chrysostomou","year":"2023","unstructured":"Chrysostomou D, Roberts LA, Marchesi JR, et al. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy[J]. Gastroenterology. 2023;164:198\u2013213.","journal-title":"Gastroenterology"},{"key":"2158_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J]. Science. 2018;359:91\u20137.","journal-title":"Science"},{"key":"2158_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J]. Science. 2018;359:97\u2013103.","journal-title":"Science"},{"key":"2158_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients[J]. Science. 2018;359:104\u20138.","journal-title":"Science"},{"key":"2158_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide[J]. Science. 2013;342:971\u20136.","journal-title":"Science"},{"key":"2158_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2[J]. Nat Biotechnol. 2019;37:852\u20137.","journal-title":"Nat Biotechnol"},{"key":"2158_CR18","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools[J]. Nucleic Acids Res. 2013;41:D590\u2013596.","journal-title":"Nucleic Acids Res"},{"key":"2158_CR19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment[J]. Science. 2013;342:967\u201370.","journal-title":"Science"},{"key":"2158_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.15252\/emmm.201606932","volume":"9","author":"M Cui","year":"2017","unstructured":"Cui M, Xiao H, Li Y, et al. Faecal microbiota transplantation protects against radiation-induced toxicity[J]. EMBO Mol Med. 2017;9:448\u201361.","journal-title":"EMBO Mol Med"},{"key":"2158_CR21","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/s41396-018-0214-x","volume":"12","author":"A Lavrinienko","year":"2018","unstructured":"Lavrinienko A, Mappes T, Tukalenko E, et al. Environmental radiation alters the gut microbiome of the bank vole Myodes glareolus[J]. ISME J. 2018;12:2801\u20136.","journal-title":"ISME J"},{"key":"2158_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jare.2019.12.003","volume":"22","author":"I Khan","year":"2020","unstructured":"Khan I, Pathan S, Li XA, et al. Far infrared radiation induces changes in gut microbiota and activates GPCRs in mice[J]. J Adv Res. 2020;22:145\u201352.","journal-title":"J Adv Res"},{"key":"2158_CR23","doi-asserted-by":"publisher","first-page":"541178","DOI":"10.3389\/fcimb.2020.541178","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, Yan H, Zhang Y, et al. Alterations of the Gut Microbiome Composition and Lipid Metabolic Profile in Radiation Enteritis[J]. Front Cell Infect Microbiol. 2020;10:541178.","journal-title":"Front Cell Infect Microbiol"},{"key":"2158_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/toxsci\/kfz144","volume":"171","author":"X Liu","year":"2019","unstructured":"Liu X, Zhou Y, Wang S, et al. Impact of Low-Dose Ionizing Radiation on the Composition of the Gut Microbiota of Mice[J]. Toxicol Sci. 2019;171:258\u201368.","journal-title":"Toxicol Sci"},{"key":"2158_CR25","doi-asserted-by":"publisher","first-page":"717636","DOI":"10.3389\/fcimb.2021.717636","volume":"11","author":"TS Zhao","year":"2021","unstructured":"Zhao TS, Xie LW, Cai S, et al. Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model[J]. Front Cell Infect Microbiol. 2021;11:717636.","journal-title":"Front Cell Infect Microbiol"},{"key":"2158_CR26","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/jpen.1744","volume":"44","author":"L Lu","year":"2020","unstructured":"Lu L, Li W, Sun C, et al. Phycocyanin Ameliorates Radiation-Induced Acute Intestinal Toxicity by Regulating the Effect of the Gut Microbiota on the TLR4\/Myd88\/NF-kappaB Pathway[J]. JPEN J Parenter Enter Nutr. 2020;44:1308\u201317.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"2158_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13073-022-01037-7","volume":"14","author":"RC Newsome","year":"2022","unstructured":"Newsome RC, Gharaibeh RZ, Pierce CM, et al. Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort[J]. Genome Med. 2022;14:35.","journal-title":"Genome Med"},{"key":"2158_CR28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00248-013-0355-4","volume":"67","author":"E Montassier","year":"2014","unstructured":"Montassier E, Batard E, Massart S, et al. 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation[J]. Microb Ecol. 2014;67:690\u20139.","journal-title":"Microb Ecol"},{"key":"2158_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Collins LB, Wali A, et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation[J]. Mol Cell. 2012;48:612\u201326.","journal-title":"Mol Cell"},{"key":"2158_CR30","unstructured":"Yang J, Wei H, Lin Y, et al. High soluble fiber promotes colorectal tumorigenesis through modulating gut microbiota and metabolites in mice[J]. Gastroenterology; 2023."},{"key":"2158_CR31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy[J]. Science. 2015;350:1084\u20139.","journal-title":"Science"},{"key":"2158_CR32","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nchembio.1661","volume":"10","author":"L Li","year":"2014","unstructured":"Li L, Yin Q, Kuss P, et al. Hydrolysis of 2\u20193\u2019-cGAMP by ENPP1 and design of nonhydrolyzable analogs[J]. Nat Chem Biol. 2014;10:1043\u20138.","journal-title":"Nat Chem Biol"},{"key":"2158_CR33","doi-asserted-by":"publisher","first-page":"15141","DOI":"10.1021\/acs.jmedchem.3c01061","volume":"66","author":"Y Cho","year":"2023","unstructured":"Cho Y, Kang M, Ji SH, et al. Discovery of Orally Bioavailable Phthalazinone Analogues as an ENPP1 Inhibitor for STING-Mediated Cancer Immunotherapy[J]. J Med Chem. 2023;66:15141\u201370.","journal-title":"J Med Chem"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02158-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02158-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02158-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:50:36Z","timestamp":1777863036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02158-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2158"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02158-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Cancer Hospital of Shandong First Medical University (approval number GBRT-043), Jinan, Shandong Province, China, in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"220"}}